What is CD388?: A Novel Drug-Fc Conjugate for Universal Flu Prevention
•
4 min read
In clinical trials, a single subcutaneous injection of the investigational drug CD388 was engineered to provide season-long protection against influenza. Developed by Cidara Therapeutics, CD388 represents a new class of antiviral known as a Drug-Fc conjugate (DFC), offering a different approach to traditional flu vaccines.
